Allergan's Tribe Deal Over Restasis Sparks Ire From Legislators
Executive Summary
Pharmaceutical manufacturers have been hoping to fly under Washington, D.C.'s radar, but Allergan's attempt to shield Restasis from the IPR process using a controversial deal with a Native American tribe, has led to calls for an investigation.